Global Clinical Chemistry Analyzer Market, By Product (Analyzers, Reagents, Calibrators, Controls, Standards, Others, Others) Analyzer Technology (Semi-Automated Clinical Chemistry Analyzers, Fully Automated Clinical Chemistry Analyzers) Test Analysis (Basic Metabolic Panel(BMP), Liver Panel, Electrolyte Panel, Renal Profile, Lipid Profile, Specialty Chemical Tests, Thyroid Function Panel) End User Analysis (Hospitals, Academic Research Centers, Diagnostic Laboratories, Others)-Industry Trends and Forecast to 2029.
Market Analysis and Size
The clinical chemistry analyzers market has seen constant innovation, which has been primarily driven by technological advancement. Ongoing research and development activities, combined with the integration of advanced software technologies in clinical laboratories, will shape the future of clinical chemistry analyzers. Furthermore, stakeholders are likely to develop new products that are in sync with laboratory requirements.
Reagents segment accounted for the largest share in the clinical chemistry analyzers market due to the frequent need for reagents in large quantities, as opposed to analyzers, is the primary factor driving the growth of this segment. Data Bridge Market Research analyses that the clinical chemistry analyzer market was valued at USD 12.3 billion in 2021 and is further estimated to reach USD 17.90 billion by 2029 during, and is expected to grow at a CAGR of 4.8% during the forecast period of 2022 to 2029.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Analyzers, Reagents, Calibrators, Controls, Standards, Others, Others) Analyzer Technology (Semi-Automated Clinical Chemistry Analyzers, Fully Automated Clinical Chemistry Analyzers) Test Analysis (Basic Metabolic Panel(BMP), Liver Panel, Electrolyte Panel, Renal Profile, Lipid Profile, Specialty Chemical Tests, Thyroid Function Panel) End User Analysis (Hospitals, Academic Research Centers, Diagnostic Laboratories, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (US), Danaher (US), Thermo Fisher Scientific Inc.( US), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson Services, Inc. (US), Siemens(Germany), ELI Tech Group (France), HORIBA, Ltd.( Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Randox Laboratories Ltd. (United Kingdom), Ortho Clinical Diagnostics(US), Nova Biomedical (US), Sysmex Corporation (Japan), Bio Systems Diagnostics Pvt. Ltd. (India), DiaSys Diagnostic Systems GmbH (Germany), Endress Hauser Management AG (Switzerland), Diatron (Hungary), SFRI. (France), EKF and Medica Corporation (UK).
|
Market Definition
A clinical chemistry analyzer is a device that measures the concentration of metabolites, electrolytes, proteins, and/or drugs in serum, plasma, urine, cerebrospinal fluid, or other bodily fluids. These devices are used in hospitals, clinics, and research laboratories.
Clinical Chemistry Analyzer Market Dynamics
Drivers
- Rise in the geriatric population
With the rapid growth of the senior population, the prevalence of age-related diseases such as hypertension, diabetes, cardiovascular, liver, and kidney disease is expected to skyrocket which will further positively influence the growth of the clinical chemistry analyzers market.
- Increase in the diseases
The rise in chronic illnesses will increase the demand for tests used to prevent, diagnose, and treat them will further accelerate the demand for the clinical chemistry analyzers market.
- Research and developments
Research and developments in clinical chemistry analyzers have enabled earlier disease detection and specialised diagnosis in oncology, gynaecology, and endocrinology, as well as larger-scale testing which is further anticipated to propel the growth of the clinical chemistry analyzer market.
Opportunities
In addition, the rising initiatives taken by the government and the funding for preventive care is further estimated to provide potential opportunities for the growth of the clinical chemistry analyzer market in the coming years.
Restraints/Challenges
On the other hand, the demand of high capital investments is further projected to impede the growth of the clinical chemistry analyzer market in the targeted period. However, the dearth of skilled laboratory technicians might further challenge the growth of the clinical chemistry analyzer market in the near future.
This clinical chemistry analyzer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical chemistry analyzer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Clinical Chemistry Analyzer Market
The pandemic of COVID-19 has had a huge impact on the clinical chemistry analyzer market. The pandemic has wreaked havoc on healthcare systems around the world, with hospitals being overloaded as the number of patients rises. Lockdowns caused by the COVID-19 pandemic caused people to postpone getting health checks, reducing the number of tests performed and reagent sales. However, post COVID-19 scenario there is an increasing demand for the development of more precise and simple testing technologies, as well as the expansion of testing structures.
Recent Development
- In July 2019, Trivitron Healthcare, an Indian health-tech company, has introduced the 'Nanolab 200,' a fully automated chemistry analyzer. The new product is an automated benchtop chemistry analyzer with a throughput of approximately 200 tests per hour. The newly launched product, which is integrated with cutting-edge liquid level detection technology, is expected to improve efficiency levels in clinical laboratories.
Global Clinical Chemistry Analyzer Market Scope and Market Size
The clinical chemistry analyzer market is segmented on the basis of product, analyzer technology, test analysis and end user analysis. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Analyzers
- Reagents
- Calibrators
- Controls
- Standards
- Others
- Others
On the basis of product, the clinical chemistry analyzer market is segmented into analyzers, reagents, calibrators, controls, standards, others, and others. Reagents has been further sub segmented into calibrators, controls, standards and others.
Analyzer Technology
- Semi-Automated Clinical Chemistry Analyzers
- Fully Automated Clinical Chemistry Analyzers
On the basis analyzer technology, the clinical chemistry analyzer market is segmented into semi-automated clinical chemistry analyzers, fully automated clinical chemistry analyzers.
Test Analysis
- Basic Metabolic Panel(BMP)
- Liver Panel
- Electrolyte Panel
- Renal Profile
- Lipid Profile
- Specialty Chemical Tests
- Thyroid Function Panel
On the basis of application, the clinical chemistry analyzer market is segmented into medical emergency, alarms and workflow management.
End User Analysis
- Hospitals
- Academic Research Centers
- Diagnostic Laboratories
- Others
On the basis of end user analysis, the clinical chemistry analyzer market is segmented into hospitals, academic research centers, diagnostic laboratories, others.
Clinical Chemistry Analyzer Market Regional Analysis/Insights
The clinical chemistry analyzer market is analysed and market size insights and trends are provided by country, product, analyzer technology, test analysis and end user analysis as referenced above.
The countries covered in the clinical chemistry analyzer market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the clinical chemistry analyzer market due to the encouraging initiatives taken by the government and increased application of practice guidelines released by healthcare organizations will further boost the growth of the clinical chemistry analyzer market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the clinical chemistry analyzer market due to the increase in the research and development investment by the global players. Moreover, the occurrence of unmapped opportunities is further anticipated to propel the growth of the clinical chemistry analyzer market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The clinical chemistry analyzer market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for clinical chemistry analyzer market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the clinical chemistry analyzer market. The data is available for historic period 2010-2020.
Competitive Landscape and Clinical Chemistry Analyzer Market Share Analysis
The clinical chemistry analyzer market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to clinical chemistry analyzer market.
Some of the major players operating in the clinical chemistry analyzer market are:
- Abbott (US),
- Danaher (US)
- Thermo Fisher Scientific Inc.( US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Johnson & Johnson Services, Inc. (US)
- Siemens(Germany)
- ELI Tech Group (France)
- HORIBA, Ltd.( Japan)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
- Randox Laboratories Ltd. (United Kingdom)
- Ortho Clinical Diagnostics(US)
- Nova Biomedical (US)
- Sysmex Corporation (Japan)
- Bio Systems Diagnostics Pvt. Ltd. (India)
- DiaSys Diagnostic Systems GmbH (Germany)
- Endress Hauser Management AG (Switzerland)
- Diatron (Hungary)
- SFRI. (France)
- EKF Medica Corporation (UK)
SKU-